# Endothelial Dysfunction, Monocyte Activation, and Vasculopathy in Patients With Obstructive Sleep Apnea (OSA) and Effect of 6-month CPAP Treatment

> **NCT01312168** · NA · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Sleep Apnea, Obstructive
- Continuous Positive Airway Pressure
- Endothelium
- Inflammation
- Vascular Function

## Interventions

- **DEVICE:** Therapeutic CPAP
- **DEVICE:** Subtherapeutic CPAP

## Key facts

- **NCT ID:** NCT01312168
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2016-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01312168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01312168, "Endothelial Dysfunction, Monocyte Activation, and Vasculopathy in Patients With Obstructive Sleep Apnea (OSA) and Effect of 6-month CPAP Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01312168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*